Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Breast Cancer
Interventions
PROCEDURE

conventional surgery

Standard of care lumpectomy or mastectomy following RFA

PROCEDURE

neoadjuvant therapy

Standard of care lumpectomy or mastectomy following RFA

PROCEDURE

radiofrequency ablation

A small diameter needle is inserted through the skin and directly into the tumor for the purpose of supplying RF current. Initial power of the RF generator will start at 5-10 watts. The power will increase by 5-10 watts every minute until impedance of the system automatically stops the RF treatment.

Trial Locations (1)

95817

University of California Davis Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER

NCT00388115 - Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ | Biotech Hunter | Biotech Hunter